Cargando…

Biosimilar therapeutics—what do we need to consider?

Patents for the first generation of approved biopharmaceuticals have either expired or are about to expire. Thus the market is opening for generic versions, referred to as ‘biosimilars’ (European Union) or ‘follow-on protein products’ (United States). Healthcare professionals need to understand the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Schellekens, Huub
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638545/ https://www.ncbi.nlm.nih.gov/pubmed/19461855 http://dx.doi.org/10.1093/ndtplus/sfn177

Ejemplares similares

Biosimilars: what do patients need to consider?
por: Skingle, Diana
Publicado: (2015)

Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
por: Doevendans, Erik, et al.
Publicado: (2019)

How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
por: Triplitt, Curtis, et al.
Publicado: (2017)

What do oncologists need to know about biosimilar products?
por: Leung, Linda K. S., et al.
Publicado: (2016)

Quality of Original and Biosimilar Epoetin Products
por: Brinks, Vera, et al.
Publicado: (2010)

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

Evolutionary ecology of Chagas disease; what do we know and what do we need?
por: Flores‐Ferrer, Alheli, et al.
Publicado: (2017)

Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity
por: Yang, Yang, et al.
Publicado: (2016)

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2019)

Biosimilar Insulins – What a Clinician Needs to Know?
por: Ghosh, Sujoy, et al.
Publicado: (2019)

Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
por: Halim, Liem Andhyk, et al.
Publicado: (2018)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Veteran homelessness in Australia: What do we know? What has been done? What do we need to do?
por: Wallace, Duncan, et al.
Publicado: (2023)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

What do we need to consider when planning, implementing and researching the use of alternatives to face-to-face consultations in primary healthcare?
por: Atherton, Helen, et al.
Publicado: (2016)

Cataract surgery – Where are we today and what do we need?
por: Heda, Aarti, et al.
Publicado: (2022)

What is vitamin A and why do we need it?
por: Gilbert, Clare
Publicado: (2013)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

What do we need for \nu counting in DELPHI ?
por: Clara, M P, et al.
Publicado: (1991)

What do we need to understand and optimize the LHC?
por: Bruning, O S
Publicado: (2010)

What Do We Need to Do for Better Casualty Support in Disasters?
por: Nekooei Moghadam, M, et al.
Publicado: (2011)

Pathogen Lists Do Not Tell Us What We Need to Do
por: Fedson, David S.
Publicado: (2019)

Neutrino Mass: what is being accomplished and what we need to do
Publicado: (2020)

Large-scale comparative neuroimaging: Where are we and what do we need?
por: Thiebaut de Schotten, Michel, et al.
Publicado: (2019)

Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
por: Askenazi, David J., et al.
Publicado: (2009)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

Familial Intracranial Aneurysms in Saudi Arabia: What Do We Need To Do?
por: Al-Jehani, Hosam, et al.
Publicado: (2016)

Neurogenic Stress Cardiomyopathy: What Do We Need to Know
por: Gopinath, Ramachandran, et al.
Publicado: (2018)

Promoting healthy behaviours – do we need to practice what we preach?
por: While, Alison E.
Publicado: (2015)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Neutrino mass: What has been accomplished,and what do we need to?
por: Kayser, B
Publicado: (1999)

P047 Sleep and diet in older adults: what do we know and what do we need to find out?
por: Gupta, C, et al.
Publicado: (2021)

What have we learned and what do we still need to learn about nPDF?
por: Paakkinen, Petja
Publicado: (2021)

Do we need to consider motion artefacts other than swallowing in carotid artery imaging?
por: Chan, Cheuk F, et al.
Publicado: (2009)

Increasing Smoking Cessation Adherence: Do We Need to Consider the Role of Executive Function and Rumination?
por: Masiero, Marianna, et al.
Publicado: (2020)

Connecting GWAS Susceptibility Genes in COPD: Do We Need to Consider TGF-β2?
por: Chen, Qing, et al.
Publicado: (2021)

Unmet Needs for Family Caregivers of Elderly People With Dementia Living in Italy: What Do We Know So Far and What Should We Do Next?
por: De Cola, Maria C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7hjkspg45lmbcbmc6rra2ajind